Maintenance. We are currently updating the site. Please check back shortly
Members login
  • TrustLaw
  • Members Portal
Subscribe Donate

GSK reports tampering of some bottles of weight-loss drug

Source: Reuters - Wed, 26 Mar 2014 14:17 GMT
Author: Reuters
hum-dis
Tweet Recommend Google + LinkedIn Email Print
Leave us a comment

March 26 (Reuters) - GlaxoSmithKline Plc said some bottles of its weight-loss drug Alli bought in the United States had been tampered with and that the U.S. Food and Drug Administration was investigating.

Consumers reported that some bottles bought in stores in seven states contained products other than the drug, the company said on Wednesday.

The company said the affected bottles could contain tablets and capsules of different shapes and colors. The actual drug is turquoise. The bottles also could be unlabeled and the lot numbers might not match the numbers on the carton, it said.

The company did not say if any consumers had taken pills from the bottles or if it was considering a recall.

Alli, which is sold by the GSK's consumer healthcare business, is approved for use without a prescription for overweight adults, in conjunction with a low-fat diet.

The company said the affected bottles were found in Alabama, Florida, Louisiana, Mississippi, New York, North Carolina and Texas. (Reporting by Vrinda Manocha in Bangalore; Editing by Ted Kerr)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of the Thomson Reuters Foundation. For more information see our Acceptable Use Policy.

comments powered by Disqus
Most Popular
TOPICAL CONTENT
Topical content
LATEST SLIDESHOW

Latest slideshow

See allSee all
FEATURED JOBS
Featured jobs